High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension

Journal of Hypertension

Volumn 24, Issue 9, 2006, Pages 1831-1840

  Florio, Pasquale ^a   Torricelli, Michela ^a   De Falco, Giulia ^a   Leucci, Eleonora ^a   Giovannelli, Alessia ^a   Gazzolo, Diego ^b   Severi, Filiberto M ^a   Bagnoli, Franco ^a   Leoncini, Lorenzo ^a   Linton, Elizabeth A ^c   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Hypertension; Intrauterine growth restriction; Intraventricular hemorrhage; Neuropeptides; Placenta; Pre eclampsia

Indexed keywords

MESSENGER RNA; UROCORTIN;

ADAPTATION; ADULT; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER FLOWMETRY; EVALUATION; FEMALE; FETAL BIOPHYSICAL PROFILE; FETOPLACENTAL UNIT; FETUS BLOOD; FETUS CIRCULATION; FETUS ECHOGRAPHY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL PLASMA; MEASUREMENT; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PERINATAL DEATH; PLACENTA CIRCULATION; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROBABILITY; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VELOCIMETRY;

EID: 33747390856     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000242408.65783.b2     Document Type: Article

References (38)

1. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53-56.
2. Reis FM, D'Antona D, Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 2002; 23:230-257.
3. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction 2002; 123:487-495.
4. Clifton VL, Read MA, Leitch IM, Boura AL, Robinson PJ, Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab 1994; 79:666-669.
5. Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 1995; 80:2888-2893.
6. Florio P, Imperatore A, Sanseverino F, Torricelli M, Reis FM, Lowry PJ, et al. The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia. J Clin Endocrinol Metab 2004; 89:4673-4677.
7. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, et al. Cloning and characterization of human urocortin. Endocrinol 1996; 137:2167-2170.
8. Petraglia F, Florio P, Gallo R, Simoncini T, Saviozzi M, Di Blasio AM, et al. Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 1996; 81:3807-3810.
9. Florio P, Rivest S, Reis FM, Simoncini T, Martinelli P, Genazzani AR, et al. Lack of gestational-related changes of urocortin gene expression in human placenta. Prenat Neonat Med 1999; 4:296-300.
10. Florio P, Vale W, Petraglia F. Urocortins in human reproduction. Peptides 2004; 25:1751-1757.
11. Cohen ML, Bloomquist W, Li D, Iyengar S. Effect of acute and subchronic subcutaneous urocortin on blood pressure and food consumption in ob/ob mice. Gen Pharmacol 2000; 34:371-377.
12. Yao X, He GW, Chan FL, Lau CW, Tsang SY, Chen ZY, et al. Endothelium-dependent and -independent coronary relaxation induced by urocortin. J Cardiac Surg 2002; 17:347-349.
13. + channels. Br J Pharmacol 2002; 135:1467-1476.
14. + channels in endothelium-independent relaxation by urocortin in the rat coronary artery. Cardiovasc Res 2003; 57:824-833.
15. Schilling L, Kanzler C, Schmiedek P, Ehrenreich H. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin- releasing factor in the rat isolated basilar artery. Br J Pharmacol 1998; 125:1164-1171.
16. Parkes DG, Vaughan J, Rivier J, Vale W, May CN. Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 1997; 272:H2115-H2122.
17. Leitch IM, Boura AL, Botti C, Read MA, Walters WA, Smith R. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 1998; 83:4510-4513.
18. Impey L, Greenwood C, Sheil O, MacQuillan K, Reynolds M, Redman C. The relation between pre-eclampsia at term and neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2001; 85:F170-F172.
19. National High Blood Pressure Education Program 2000. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
20. Campbell S, Thoms A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynaecol 1977; 84:165-174.
21. ACOG Committee Opinion. Inappropriate use of the terms fetal distress and birth asphyxia. Int J Gynecol Obstet 1998; 61: 309-310.
22. Severi FM, Bocchi C, Visentin A, Falco P, Cobellis L, Florio P, et al. Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2002; 19:225-228.
23. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight < 1,500 gm. J Pediatr 1978; 92:529-534.
24. Florio P, Torricelli M, Galleri L, De Falco G, Leucci E, Calonaci G, et al. High fetal urocortin levels at term and preterm labor. J Clin Endocrinol Metab 2005; 90:5361-5365.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408.
26. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39:561-577.
27. Richardson WS, Wilson MC, Guyatt GH, Cook DJ, Nishikawa J. Users' guides to the medical literature: XV. How to use an article about disease probability for differencial diagnosis. Evidence-based medicine working group. JAMA 1999; 281:1214-1219.
28. Oki Y, Sasano H. Localization and physiological roles of urocortin. Peptides 2004; 25:1745-1749.
29. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, et al. Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 1999; 84:2802-2806.
30. Jain V, Longo M, Ali M, Saade GR, Chwalisz K, Garfield RE. Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J Soc Gynecol Investig 2000; 7:153-160.
31. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000; 24:410-414.
32. Chang TC, Robson SC, Spencer JA, Gallivan S. Prediction of perinatal morbidity at term in small fetuses: comparison of fetal growth and Doppler ultrasound. Br J Obstet Gynaecol 1994; 101:422-427.
33. Rademaker MT, Charles CJ, Espiner EA, Fisher S, Frampton CM, Kirkpatrick CM, et al. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol 2002; 40:1495-1505.
34. Scarabelli TM, Pasini E, Stephanou A, Comini L, Curello S, Raddino R, et al. Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J Am Coll Cardiol 2002; 40:155-161.
35. Chanalaris A, Lawrence KM, Stephanou A, Knight RD, Hsu SY, Hsueh AJ, et al. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. J Mol Cell Cardiol 2003; 35:1295-1305.
36. Facci L, Stevens DA, Pangallo M, Franceschini D, Skaper SD, Strijbos PJ. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. Neuropharmacology 2003; 45:623-636.
37. Elliott-Hunt CR, Kazlauskaite J, Wilde GJ, Grammatopoulos DK, Hillhouse EW. Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J Neurochem 2002; 80:416-425.
38. Lezoualc'h F, Engert S, Berning B, Behl C. Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB. Mol Endocrinol 2000; 14:147-159.